1. C S C S United States says:

    "The study analysis showed that S-IgG levels best predicted the neutralization activity against BQ.1.1. Yet, 59.6% of the individuals with detectable S-IgG levels over 1000 binding antibody units (BAU)/ml showed no significant neutralizing activity against BQ.1.1. It highlighted that low S-IgG levels were inadequate for accurate assessment of the neutralization activity against BQ.1.1." Layperson here but this sounds like the method to measure vaccine effectiveness by measuring increased levels in the blood doesn't translate to actual immunity against the virus. This has been a criticism of how Covid jabs "effectiveness" has been lacking but in a lab it appears to provide a boost that doesn't translate to actual immunity and real world data seems to show any benefits turn negative over time and it doesn't seem like it is understood why. Boosting for high antibody levels while not preventing infection seems like a sure way to create variants that can evade the leaky jabs.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.